Growth and Tolerance of Young Infants Fed Infant Formulas
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Connecticut
-
Norwich, Connecticut, United States, 06360
- Norwich Pediatric Group, PC
-
-
Florida
-
St. Petersburg, Florida, United States, 33710
- SCORE Physician Alliance, LLC
-
-
Indiana
-
Indianapolis, Indiana, United States, 46038
- Northpoint Pedicatrics, LLC
-
-
Kentucky
-
Owensboro, Kentucky, United States, 42303
- Springs Medical Research, LLC
-
-
Nevada
-
Las Vegas, Nevada, United States, 89104
- Clinical Research Center of Nevada
-
-
North Carolina
-
Cary, North Carolina, United States, 27518
- Cary Pediatric Center
-
-
Ohio
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
Huber Heights, Ohio, United States, 45424
- Ohio Pediatric Research Association, Inc.
-
Mayfield Heights, Ohio, United States, 44124
- Institute of Clinical Research
-
Parma, Ohio, United States, 44129
- The Cleveland Pediatric Research Center
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Sanford Clinic Family Medicine
-
-
Texas
-
Longview, Texas, United States, 75605
- DCOL Center for Clinical Research
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy infant
- full term
- birth weight > 2490 g
- 0 to 8 days of age
- parent/physician agree to not use medications affecting tolerance/growth
- parent agrees to sole source feeding of study formula
- parent agrees to not use vitamin/mineral supplements
- parent has signed consent/HIPAA authorization
Exclusion Criteria:
- any maternal, fetal, or infant history affecting growth and tolerance
- participation in any other study not preapproved by Abbott
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Infant formula, alternate protein source
Experimental infant formula with alternate protein source
|
experimental infant formula to be fed ad libitum
|
|
Active Comparator: Infant formula powder
|
powdered infant formula to be fed ad libitum
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Weight gain
Time Frame: 119 days
|
119 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
gastrointestinal tolerance
Time Frame: 119 days
|
Stool characteristics, number of stools per day, and number of feedings associated with spit up or vomit
|
119 days
|
|
Anthropometric variables
Time Frame: 119 days
|
Length gain per day and head circumference gain per day
|
119 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Marlene Borschel, PhD, Abbott Nutrition
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- AK92
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.